Bionano Genomics, Inc. (BNGO) vs GlucoTrack, Inc. (GCTK)
Bionano Genomics, Inc. and GlucoTrack, Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $19.9M against $1.9M — 10.8× the size. Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −106.6%) and the higher return on invested capital (0.00% vs −81.7%). Across the 17 metrics below, Bionano Genomics, Inc. leads on 9 and GlucoTrack, Inc. on 8.
Valuation
Profitability
| Metric | BNGO | GCTK | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 47.51% | 0.00% | 54.62% |
| Operating margin | (106.67%) | 0.00% | 1.64% |
| Net margin | (106.58%) | 0.00% | 0.00% |
| Free cash flow margin | (67.87%) | 0.00% | 1.61% |
| Return on equity | (83.56%) | (620.63%) | 0.00% |
| Return on assets | (52.04%) | (272.48%) | 0.00% |
| Return on invested capital | (81.68%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack